tirzepatide head to head semaglutide Weight Loss Wars: and Go Head-to-Head – Who Wins? Tirzepatide vs Semaglutide 2026: 22%

Improved oral hygiene care attenuates the cardiovascular risk of oral health disease: a population-based study from Korea [J]

Consider clinical weight loss treatment through Klinic if your BMI is 30 or higher, or 27 with comorbidities like hypertension or sleep apnea

[4] For patients taking Mounjaro, current evidence does not show a direct interaction with tirzepatide or consistent adverse glycaemic effects from artificial sweeteners, though individual variability in appetite response may occur

Ertugliflozin (Steglatro, Merck) Indication and Clinical Profile 1,2 : Ertugliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that has been approved for the treatment of type 2 diabetes (DM2) in adult patients as an adjunct to diet and exercise